Biocon Limited is a global biopharmaceutical company specializing in biosimilars, generics, and novel biologics. With a strong presence in over 120 countries, Biocon is at the forefront of innovation in diabetes, oncology, and immunology treatments. Given the scale and complexity of its operations, data fragmentation across multiple business units, R&D centers, and supply chain ecosystems hindered efficiency and real-time decision-making.
Despite being a data-driven organization, Biocon faced critical inefficiencies due to data silos and outdated data management practices.
Key Challenges:
Despite these hurdles, Cipla aimed to create a seamless experience for its users, reinforcing its commitment to innovation and accessibility in healthcare.
INT. implemented a fully integrated Enterprise Data Warehouse (EDW) solution to centralize Biocon’s entire data landscape, ensuring real-time access, improved accuracy, and cost-effective data management.
INT.’s Enterprise Data Warehouse transformed Biocon’s data landscape, delivering measurable efficiency gains and cost savings.
Cost reduction in data operations by significantly decreasing the operational team size
Increase in data accuracy
We see INT. as a future partner for their own expansion. After almost a decade of working together, we will need INT’s support for our new steps in the growing markets.
